BATROXOBIN
UNII 47RYF40GA9

Substance Identification & Data

This profile provides standardized clinical and technical data for Batroxobin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 47RYF40GA9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 9039-61-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
47RYF40GA9
CAS Registry Number
9039-61-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BATROXOBIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
3361
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Batroxobin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BATROXOBIN

Common Names & Synonyms

BATROXOBIN [INN]
BATROXOBIN [JAN]
BATROXOBIN [MI]
BATROXOBIN [WHO-DD]
BOTHROPS ATROX VENOM SERINE PROTEASE (MW 43000)
DEFIBRASE [WHO-DD]

Brand / Trade Names

DEFIBRASE